Description
Ipamorelin is a selective growth hormone secretagogue (GHS) peptide that has been investigated for its activity as a ghrelin mimetic. With ≥99% purity confirmed through HPLC UV testing, Ipamorelin has been studied in preclinical and laboratory research for its ability to stimulate growth hormone release with high receptor selectivity and minimal impact on other endocrine pathways.
Research Highlights (from published studies):
-
Examined in preclinical models for selective growth hormone release
-
Studied for its receptor activity compared to earlier GHRPs
-
Investigated for its metabolic and endocrine signaling profile in laboratory research
-
Frequently evaluated in combination studies with GHRH analogs such as CJC-1295 No DAC
Examples of Research Contexts:
-
Laboratory studies exploring ghrelin receptor activity and GH release
-
Preclinical models assessing endocrine selectivity and safety profiles
-
Experimental investigations of stacked peptide research protocols
-
Comparative research with other growth hormone secretagogues
⚠️ Disclaimer: This product is provided strictly for laboratory research use only. It is not approved for human consumption, medical use, or dietary supplementation. Peptara does not make claims of safety, efficacy, or therapeutic benefits in humans.